Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,390.00    108.00 (4.73%)
Bid:
2,380.00
Ask:
2,384.00
Spread: 4.00 (0.168%)
Market Cap: £7.67b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Director/PDMR Shareholding

31 Mar 2026 16:50

RNS Number : 9133Y
Bunzl PLC
31 March 2026
 

Notification of transactions by person discharging managerial responsibilities

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Diana Breeze

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director of Group Human Resources

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Bunzl plc

b)

 

LEI

 

 

213800Q1Q9DV4L78UM09

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 32 1/7 pence each

 

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 9,128 shares at nil cost following the exercise of an award granted in April 2020 under Part B of the Bunzl Long Term Incentive Plan (2014) and subsequent sale of 4,301 shares at £22.4111 per share to cover the costs of exercise, including tax and dealing costs.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

£22.4111

4,301

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

N/A single transaction

 

 

N/A

e)

 

Date of the transaction

 

 

2026-03-31

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 32 1/7 pence each

 

GB00B0744B38

b)

 

Nature of the transaction

 

 

Acquisition of 4,653 shares at nil cost following the exercise of an award granted in March 2023 (and related dividend equivalent shares) under the Bunzl Deferred Annual Share Bonus Scheme and subsequent sale of 4,653 shares at £22.383572 per share.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

£22.383572

4,653

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

N/A single transaction

 

 

N/A

e)

 

Date of the transaction

 

 

2026-03-31

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEFLFXQXLZBBL
Date   Source Headline
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20258:00 amRNSAdditional Listing
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20254:06 pmRNSAnnual Financial Report
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20255:40 pmRNSIssue of Debt
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20255:05 pmRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20255:07 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20255:25 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 202511:22 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 202511:28 amRNSTotal Voting Rights
3rd Mar 202510:00 amRNSDividend Declaration
3rd Mar 20257:01 amRNS2025 Share Buyback Programme - Update
3rd Mar 20257:00 amRNSFinal Results
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20252:58 pmRNSHolding(s) in Company
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20255:26 pmRNSDirector/PDMR Shareholding
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20255:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.